Bioanalysis of peptides service by LGC – DDS

Manufacturer LGC – DDS  |  Available Worldwide
LGC's bioanalytical solutions have helped their clients develop new peptide therapeutics to improve the quality of life.  Applying their experience and cutting-edge technology, LGC have developed and validated methods using LC-MS/MS to quantify levels of peptides in plasma at levels as low as 10 pg/mL.


Bioanalysis of peptides service by LGC – DDS product image
Bioanalysis of peptides service
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

LGC have become experts in offering bioanalytical solutions to their clients using LC-MS/MS technology.

LGC's expertise extends beyond determination of peptide drugs in biological matrices. LGC also have experience in the quantitation of proteins (therapeutic drugs and biomarkers) as well as mAbs using LGC's BioMS™ platform.

LGC's ntegrated services include:

  • Fast method development for discovery compounds
  • Method development and validation for GLP TK studies and GCP clinical trials
  • Fast turnaround for Phase I Clinical Studies
  • Logistical support for clinical sample management including sample collection kit production and supply of sampling kits, labels, investigator manual and shipping

High quality reporting and data management

  • Rapid turnaround of analytical data, draft and final reports, using LGC's templates or yours
  • Specialist software to support SEND/SDTM data requirements
  • eCTD compliant reports
  • PK/TK profiling and reporting using WinNonlin™
  • Certified as GLP and GCP compliant by MHRA, successful EMA audits
  • Dedicated independent Quality Assurance, pharmacokinetic and data management personnel

Product Overview

Bioanalysis of peptides service by LGC – DDS product image

Bioanalysis of peptides service

Manufacturer LGC – DDS  |  Available Worldwide

Be the first to review this product